Market Competition and Healthcare Policy

Insurance exists to protect enrollees against their financial exposure to catastrophically high-cost low-probability events. Indeed, health insurance began as sickness funds, where workers made weekly contributions to a fund that would temporarily provide a reduced wage to those too ill to work.

Comparison of prior authorization across insurers: cross-sectional evidence from Medicare Advantage

The goal of this webinar is to discuss the ecosystem of markets for blood and blood components in the US, the structure of the market ecosystem, the challenges faced, and the steps underway to address the challenges and ensure a stable supply of blood and blood components for patients in need.

Michael's upcoming article in the Journal of Risk and Uncertainty

Melinda sat down to discuss the report on 2022 health care spending from the CMS Office of the Actuary.

"Happy to become a new member of @MHCCMD Payment Model Work Group" Read more on her announcement here.

What is the association of recreational and medical cannabis legalization with opioid prescriptions and fatal overdoses in the US?

To validate imputation methods used to infer plan-level deductibles and determine which enrollees are in high-deductible health plans (HDHPs) in administrative claims datasets

Biosimilar uptake in the United States is limited. It has not been comprehensively studied in Medicare Advantage (MA).

HBHI is pleased to announce our five pilot grant awardees for our 2024 cohort.